At least 80% of every dollar donated goes to its mission of saving lives from opioid overdoses. If this policy aligns with your passions and values, you can give with confidence.

This charity focuses on (1) opioid addiction research for treatment and prevention and (2) funding scientists and organizations to develop non-opioid, non-addictive pain management solutions as the new standard of care in healthcare systems worldwide.

Established in 2016, it is a Delaware non-profit corporation recognized as tax exempt under Section 501(c)(3) of the U.S. Internal Revenue Code. Its tax ID is 81-4117507.

It submitted a comment letter to the U.S. Food & Drug Administration (FDA) recommending approval of Naloxone for over-the-counter sales not requiring a prescription. Naloxone saves lives by reversing the effects of an opioid, heroin, or fentanyl overdose. In March 2023, the FDA approved Naloxone nasal spray for over-the-counter sales despite objections of certain pharmaceutical companies which sought to keep Naloxone prescription based. Now, families, employers, and event sponsors can easily keep Naloxone nasal spray on hand to quickly administer to an overdosing person as time is of the essence, while waiting for professional medical help to arrive.

It projects that without urgent intervention, 1.2 million people in the U.S. and Canada will die from opioid related overdoses by the end of 2029, in addition to the more than 600,000 who have died since 1999.